Amgen and Zai Lab have agreed to run a global clinical trial combining two DLL3 targeted therapies for small cell lung cancer ...

Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.

A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...

India, April 14 -- Is COVID-19 really linked to lung cancer risk? Yes, a new scientific study from the Marshall University ...

When doctors review diagnostic medical scans for lung cancer, they sometimes spot abnormalities unrelated to the lungs. New research shows that some of those abnormalities could be signs of other ...

A model integrating deep learning with clinical and epidemiologic data may significantly improve lung cancer risk prediction based on LDCT screening.

A patient walks into a thoracic surgery consultation with a small lung tumor, stage I on every scan, and every conventional ...

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...

A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in ...

New research suggests heavy marijuana smoking may raise the risk of lung cancer risk, as well as head and neck cancer.

Investigators sought to determine whether the NHS Lung Cancer Screening Programme met its goals for nationwide lung cancer screening.